Bowel Disease Linked to Depression, Anxiety and Substance Misuse
Published August 6, 2026

People living with inflammatory bowel disease face a measurably higher risk of co-occurring disorders including depression, anxiety, and substance misuse. That risk starts years before the digestive diagnosis is ever made. That’s the finding of a nationwide Swedish cohort study.
The pattern offers a useful illustration of why behavioral health and physical health are difficult to treat in separate rooms.
The Swedish Study’s Findings
Researchers analyzed more than 40,000 Swedish patients with inflammatory bowel disease diagnosed between 2007 and 2023. They compared that group against nearly 180,000 people from the general population and against 26,000 full siblings who did not have the disease.
Risk of psychiatric illness began rising two to three years before an inflammatory bowel disease diagnosis. It peaked within the first six months after diagnosis with a 50% increase and remained elevated a decade later at a 19% increase.
The increase was driven largely by major depressive and anxiety disorders and substance misuse. Prescriptions for antidepressants and anxiolytics rose in the year before diagnosis and stayed elevated for at least five years afterward.
Results held across Crohn’s disease, ulcerative colitis, and unclassified inflammatory bowel disease. Absolute risks were highest among patients whose disease began in childhood and among those with a family history of psychiatric conditions.
Since the association persisted even when patients were compared with their own siblings who didn’t have the disease, the researchers concluded that shared family genetics or environmental factors alone don’t explain the link.
The Risk Starts Before Diagnosis
The pre-diagnosis window of this study hasn’t been examined closely before. Most prior research looked only at what happens after someone learns they have inflammatory bowel disease.
Several explanations are under consideration rather than settled. Scientists point to the protracted course of the disease, disrupted communication along the gut-brain axis, reduced social functioning, diminished quality of life, and genetic factors shared between the two conditions. People often live with unexplained pain, urgency, and fatigue for a long stretch before anyone names the cause, and that period alone can take a toll.
Thus the need for stronger coordination between treatment teams. “It is time to actively manage psychiatric conditions in patients with IBD,” noted lead author Dr. Jiangwei Sun.
Understanding Co-Occurring Disorders and Treating Them
Co-occurring disorders, sometimes called dual diagnosis, describe the presence of a mental health condition and a substance use disorder at the same time. The term also gets used more broadly for a chronic medical condition running alongside a psychiatric one, which this study describes.
Treating these conditions separately tends to produce worse results than treating them together. Someone drinking heavily to manage anxiety usually won’t stay sober if the anxiety goes unaddressed, and an individual whose depression is tangled up with chronic pain needs care for both conditions. Integrated treatment means one coordinated plan rather than parallel appointments that never talk to each other.
Behavioral and mental health treatment facilities handle co-occurring disorders typically by drawing on evidence-based approaches. Group behavioral therapy targets the thought and emotion patterns that drive low mood and substance use. Trauma-focused therapy matters for folks whose medical history includes frightening or invasive experiences.
Medication management and even probiotics run alongside therapy in many cases, and coordination between a prescribing psychiatrist and a gastroenterologist becomes important when drug interactions are a factor.
The study’s authors recommend screening for psychiatric symptoms early, beginning at the initial gastrointestinal evaluation. Then, build psychological care into routine inflammatory bowel disease management. This approach can lead to a stronger outcome than referring out only after a crisis.
Care Starts Now
For anyone living with a chronic illness and noticing changes in mood, anxiety, or your relationship with alcohol or other substances, look for programs that treat both sides at once rather than one at a time.
Feel free to browse our online listings for dual diagnosis treatment programs and mental health treatment facilities in your area and ask directly whether a facility coordinates with your existing medical providers.
Also, call 800-908-4823 (Sponsored) for free and confidential assistance to discuss mental health and substance use treatment with an expert.
Articles About Alcohol & Treatment

Problematic Social Media Use Linked to Rising ADHD in Boys
Problematic Social Media Use Linked to Rising ADHD in Boys Published August 7, 2026 A study of more than 11,000 US adolescents suggests that rising problematic social media use may precede worsening ADHD symptoms in boys. The findings pull behavioral health and co-occurring disorders into the same conversation for families, especially those with young men,…

Bowel Disease Linked to Depression, Anxiety and Substance Misuse
Bowel Disease Linked to Depression, Anxiety and Substance Misuse Published August 6, 2026 People living with inflammatory bowel disease face a measurably higher risk of co-occurring disorders including depression, anxiety, and substance misuse. That risk starts years before the digestive diagnosis is ever made. That’s the finding of a nationwide Swedish cohort study. The pattern…

Psychiatrists Debate AI Suicide Screening in Mental Health Care
Psychiatrists Debate AI Suicide Screening in Mental Health Care Published August 6, 2026 Emergency departments are often the last point of contact for people at risk of suicide, and a growing question in mental health treatment asks whether accrediting bodies should require hospitals to run artificial intelligence risk scoring on those patients. Experts now weigh…
Browse Treatment Centers by State
-
PennsylvaniaBowling Green Brandywine Treatment Center
1375 Newark Road Kennett Square, Pennsylvania 19348
Treatment Programs
- Dual Diagnosis
- Drug Rehab
- Adult Program
- +3
-
OregonRainbow Lotus Healing Center
35890 7th Street Nehalem, Oregon 97131
Treatment Programs
- Drug Rehab
- +-2
-
GeorgiaCircle of Recovery Inc
3125 Presidential Parkway, Suite 217 Atlanta, Georgia 30034
Treatment Programs
- Dual Diagnosis
- Drug Rehab
- Young Adult Rehab
- +1
-
VirginiaMiddle Peninsula Northern Neck Bowden Street
129 Bowden Street Saluda, Virginia 23149
Treatment Programs
- Alcohol Rehab
- Dual Diagnosis
- Opioid Addiction
- +4

